发明名称 |
Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
摘要 |
The present invention relates to a new crystalline modification of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,S-dihydro-1H-pyrrolizin-S-ylacetic acid which is referred to as polymorph B. It has a peak in the solid state 13C-NMR spectrum (with adamantane as external reference standard; CH group d=29.45 ppm) in the range from 179.8 to 180.2 ppm and can be processed directly to a pharmaceutical formulation.
|
申请公布号 |
US8034837(B2) |
申请公布日期 |
2011.10.11 |
申请号 |
US20060886933 |
申请日期 |
2006.03.20 |
申请人 |
MERCKLE GMBH |
发明人 |
ALBRECHT WOLFGANG;KAMMERMEIER THOMAS;STRIEGEL HANS-GUNTER;MERCKLE PHILIPP;LAUFER STEFAN |
分类号 |
A61K31/407;C07D209/52 |
主分类号 |
A61K31/407 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|